Metropolis Healthcare Ltd. is introducing its three-day initial public offering on Wednesday as the company is seeking to pare their holding in some diagnostic company. The company targets to ripe Rs. 1200-1205 crore by selling 1.36 crore shares at Rs. 877-880 per share in a homogenous offer-for-sale, as stated to its red herring prospectus.
From the promoter family, Sushil Kanubhai Shah will sell 62.7 lakh shares, and investor CA Lotus Investments—a subsidiary of U.S.-based private equity firm Carlyle Group—will offload 74.1 lakh shares. The maiden offering—the third after Dr. Lal PathLabs Ltd. and Thyrocare Technologies Ltd.—values Metropolis Healthcare at more than Rs 4,400 crore.
Metropolis Healthcare is active and working across 19 states, especially in the west and south India. It takes control through the ‘hub-and-spoke’ design that includes reference laboratories, satellite laboratories, and collection centers,
Read EquityPandit’s Nifty Pharma Outlook for the Week